Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George Han

Showing results (91-100 of 105) with videos related to

Pageof 11
Sort By:
Archives of Dermatological Research|July 18, 2024
Ritlecitinib, a JAK3/TEC family kinase inhibitor, stabilizes active lesions and repigments stable lesions in vitiligoYuji Yamaguchi, Elena Peeva, Ester Del Duca, et al.
Cutis|February 18, 2022
Teledermatology During the COVID-19 Pandemic: Lessons Learned and Future DirectionsZachary H Hopkins, George Han, Trilokraj Tejasvi, et al.
Journal of the American Academy of Dermatology|September 22, 2023
Development of the Generalized Pustular Psoriasis Clinical Assessment ToolAmit Garg, Megan H Noe, Milan J Anadkat, et al.
The Journal of Clinical and Aesthetic Dermatology|January 25, 2021
The Use of Brodalumab in Three Patients with Psoriasis and Psychiatric ComorbiditiesRyan Rivera-Oyola, Roselyn Stanger, Graham H Litchman, et al.
Journal of Psoriasis and Psoriatic Arthritis|September 19, 2024
Factors Associated with Multi-Biologic Use in Psoriasis Patients at an Academic Medical Center and Review of Biologic SurvivalEdward Hadeler, Sugandh Kumar, Samuel Yeroushalmi, et al.
MMWR. Morbidity and Mortality Weekly Report|April 27, 2018
Three Rotavirus Outbreaks in the Postvaccine Era - California, 2017Rachel M Burke, Jacqueline E Tate, Nora Barin, et al.
Journal of the American Academy of Dermatology|February 18, 2021
Baricitinib in patients with moderate-to-severe atopic dermatitis: Results from a randomized monotherapy phase 3 trial in the United States and Canada (BREEZE-AD5)Eric L Simpson, Seth Forman, Jonathan I Silverberg, et al.
JAAD International|June 5, 2023
National Psoriasis Foundation Telemedicine Task Force guidance for management of psoriatic disease via telemedicineNatalia Pelet Del Toro, Rayan Yahia, Steven R Feldman, et al.
Journal of the American Academy of Dermatology|November 12, 2022
Efficacy and safety of oral ritlecitinib for the treatment of active nonsegmental vitiligo: A randomized phase 2b clinical trialKhaled Ezzedine, Elena Peeva, Yuji Yamaguchi, et al.
MMWR. Morbidity and Mortality Weekly Report|September 4, 2025
Highly Pathogenic Avian Influenza A(H5N1) Virus Infection in a Child with No Known Exposure - San Francisco, California, December 2024-January 2025Farrell A Tobolowsky, Eric Morris, Lina Castro, et al.
Pageof 11

Showing results (91-100 of 105) with videos related to

Sort By:
Pageof 11
Archives of Dermatological Research|July 18, 2024
Ritlecitinib, a JAK3/TEC family kinase inhibitor, stabilizes active lesions and repigments stable lesions in vitiligoYuji Yamaguchi, Elena Peeva, Ester Del Duca, et al.
Cutis|February 18, 2022
Teledermatology During the COVID-19 Pandemic: Lessons Learned and Future DirectionsZachary H Hopkins, George Han, Trilokraj Tejasvi, et al.
Journal of the American Academy of Dermatology|September 22, 2023
Development of the Generalized Pustular Psoriasis Clinical Assessment ToolAmit Garg, Megan H Noe, Milan J Anadkat, et al.
The Journal of Clinical and Aesthetic Dermatology|January 25, 2021
The Use of Brodalumab in Three Patients with Psoriasis and Psychiatric ComorbiditiesRyan Rivera-Oyola, Roselyn Stanger, Graham H Litchman, et al.
Journal of Psoriasis and Psoriatic Arthritis|September 19, 2024
Factors Associated with Multi-Biologic Use in Psoriasis Patients at an Academic Medical Center and Review of Biologic SurvivalEdward Hadeler, Sugandh Kumar, Samuel Yeroushalmi, et al.
MMWR. Morbidity and Mortality Weekly Report|April 27, 2018
Three Rotavirus Outbreaks in the Postvaccine Era - California, 2017Rachel M Burke, Jacqueline E Tate, Nora Barin, et al.
Journal of the American Academy of Dermatology|February 18, 2021
Baricitinib in patients with moderate-to-severe atopic dermatitis: Results from a randomized monotherapy phase 3 trial in the United States and Canada (BREEZE-AD5)Eric L Simpson, Seth Forman, Jonathan I Silverberg, et al.
JAAD International|June 5, 2023
National Psoriasis Foundation Telemedicine Task Force guidance for management of psoriatic disease via telemedicineNatalia Pelet Del Toro, Rayan Yahia, Steven R Feldman, et al.
Journal of the American Academy of Dermatology|November 12, 2022
Efficacy and safety of oral ritlecitinib for the treatment of active nonsegmental vitiligo: A randomized phase 2b clinical trialKhaled Ezzedine, Elena Peeva, Yuji Yamaguchi, et al.
MMWR. Morbidity and Mortality Weekly Report|September 4, 2025
Highly Pathogenic Avian Influenza A(H5N1) Virus Infection in a Child with No Known Exposure - San Francisco, California, December 2024-January 2025Farrell A Tobolowsky, Eric Morris, Lina Castro, et al.
Pageof 11